drugset / Trial / NCT06113848

Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy

NCT06113848

Phase 3 Unknown 80 enrolled Tianjin Huanhu Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the feasibility and efficacy of intra-arterial TNK and albumin for patients with acute ischemic stroke after successful thrombectomy and whether there is a synergistic effect between TNK and albumin.

Timeline

Start
2023-09-07
Primary completion
2024-09-07
Completion
2024-09-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic Other
Comparator TNK Unknown Other

Indications